Loading company…
Neuramedy develops pharmaceutical treatments for neurodegenerative diseases from its base in Seoul, South Korea.
Founded in 2019 and based in Seoul, South Korea, Neuramedy develops pharmaceutical treatments for neurodegenerative diseases. The company is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in